These data suggest that patients in the low LMF_index group exhibit higher ACSL4 expression, indicating increased ferroptosis sensitivity, which may contribute to greater CD8+ T cell infiltration and enhanced anti-tumor immunity. The gene discussed is ACSL4; the disease is neoplasm.